Correspondence 0001213900-23-001613 from CollPlant Biotechnologies Ltd (CLGN)

CollPlant Biotechnologies Ltd
Date: Jan. 9, 2023 · CIK: 0001631487 · Accession: 0001213900-23-001613

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-269087

Date

January 9, 2023

Author

Eran Rotem

Form

CORRESP

Company

CollPlant Biotechnologies Ltd

Letter

CollPlant Biotechnologies Ltd.

4 Oppenheimer, Weizmann Science Park

Rehovot 7670104, Israel

January 9, 2023

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: CollPlant Biotechnologies Ltd.

Registration Statement on Form F-3

File No. 333-269087

VIA EDGAR

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, CollPlant Biotechnologies Ltd. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form F-3 (File No. 333-269087) of the Registrant (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will be declared effective at 4:30 p.m., Eastern Time, on January 10, 2023 or as soon thereafter as may be practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Eyal Peled at (212) 801-9210. The Company hereby authorizes Mr. Peled to orally modify or withdraw this request for acceleration.

Very truly yours,
COLLPLANT BIOTECHNOLOGIES LTD.

Show Raw Text

CORRESP
1
filename1.htm

CollPlant Biotechnologies Ltd.

4 Oppenheimer,
Weizmann Science Park

Rehovot 7670104, Israel

January 9, 2023

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    CollPlant Biotechnologies Ltd.

    Registration Statement on Form F-3

    File No. 333-269087

VIA EDGAR

Ladies and Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended, CollPlant Biotechnologies Ltd. (the “Registrant”) hereby respectfully requests
that the effectiveness of the Registration Statement on Form F-3 (File No. 333-269087) of the Registrant (the “Registration Statement”)
be accelerated so that the Company’s Registration Statement will be declared effective at 4:30 p.m., Eastern Time, on January 10,
2023 or as soon thereafter as may be practicable.

The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP,
by calling Eyal Peled at (212) 801-9210. The Company hereby authorizes Mr. Peled to orally modify or withdraw this request for acceleration.

    Very truly yours,

    COLLPLANT BIOTECHNOLOGIES LTD.

    By:
    /s/ Eran Rotem

    Name:
    Eran Rotem

    Title:
    Deputy CEO and Chief Financial Officer

 cc: Gary Emmanuel (Greenberg Traurig, LLP)

SecProbe.io